1352319-51-7

Basic information

• Product Name: N-(cis-4-((6-(4-methyl-3-sulfamoylphenylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)cyclohexyl)acetamide
• Synonyms: N-(cis-4-((6-(4-methyl-3-sulfamoylphenylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)cyclohexyl)acetamide
• CAS NO: 1352319-51-7
• Molecular Weight: 457.556
• Mol File: 1352319-51-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(cis-4-((6-(4-methyl-3-sulfamoylphenylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)cyclohexyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(cis-4-((6-(4-methyl-3-sulfamoylphenylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)cyclohexyl)acetamide(1352319-51-7)
• EPA Substance Registry System: N-(cis-4-((6-(4-methyl-3-sulfamoylphenylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)cyclohexyl)acetamide(1352319-51-7)

Safety Data

• Hazardous Substances Data: 1352319-51-7(Hazardous Substances Data)

Upstream product

• 1352319-14-2 tert-butyl cis-4-((6-chloro-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)cyclohexylcarbamate 
• 6973-09-7 5-amino-2-methylbenzenesulfonamide 
• 1352319-35-7 5-(1-((cis-4-aminocyclohexyl)methyl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino)-2-methylbenzenesulfonamide 
• 75-36-5 acetyl chloride 

Relevant articles and documents

NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS

The present disclosure is directed to novel compounds of Formula (I), pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are as defined herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, Crohn's disease, psoriasis and asthma.